NCT07025005
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Damanhur Oncology Center Damanhur, El- Behira, Egypt
- Tanta University Tanta, El-Gharbya, Egypt
Clinical trial condition
Multiple Myeloma, Neoplasms
Explore clinical trials studying Multiple Myeloma, Neoplasms. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
Multiple Myeloma, Neoplasms trial results
NCT06908629
- Conditions
- Blood Protein Disorders, Cancer, Cancer Survivors, +25 more
- Locations
-
- Karmanos Cancer Institute Detroit, Michigan, United States
Not Yet Recruiting
5p15/ 9q22/ 15q22 Hyperdiploidy and Their Significance in Multiple Myeloma Patients
NCT06667583
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
NCT01524978
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Arizona Oncology Tucson, Arizona, United States
- Rocky Mountain Cancer Centers, LLP Aurora, Colorado, United States
- Massachusetts General Hospital;Oncology Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT01804140
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Sedona, Arizona, United States
- Tucson, Arizona, United States
- Burbank, California, United States
- Rancho Cucamonga, California, United States
Active, Not Recruiting
Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma
NCT06924424
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhengzhou, Henan, China